Myogem Health Company S.L.

Myogem Health Company S.L. Myogem Health Company S.L. is a Spin-off of Inkemia IUCT Group, that focuses its attention on R&D o

Gracias a Asociacion BENE por organizar este espléndido día a favor de la Distrofia Miotónica.
21/10/2017

Gracias a Asociacion BENE por organizar este espléndido día a favor de la Distrofia Miotónica.

De camino a Bilbao, hoy es el día!!Jornada organizada en colaboración con Asociacion BENE
20/10/2017

De camino a Bilbao, hoy es el día!!Jornada organizada en colaboración con Asociacion BENE

16/10/2017

Charla "Desarrollo del complemento alimenticio MYO-DM y su aplicación en Distrofia Miotónica"

El próximo 20 de Octubre hablaremos de Myo-DM en Bilbao, evento organizado en colaboración con la Asociacion BENE. Hasta...
04/10/2017

El próximo 20 de Octubre hablaremos de Myo-DM en Bilbao, evento organizado en colaboración con la Asociacion BENE. Hasta pronto

Joining J&J Innovation training day organized by ASEBIO
26/09/2017

Joining J&J Innovation training day organized by ASEBIO

Today at MDF annual conference, thanks to Myotonic Dystrophy Foundation
09/09/2017

Today at MDF annual conference, thanks to Myotonic Dystrophy Foundation

Cloudy day at IDMC-11, today session about cell models for Myotonic Dystrophy.
09/09/2017

Cloudy day at IDMC-11, today session about cell models for Myotonic Dystrophy.

IDMC-11 Session about specific Myotonic Dystrophy features : CNS, Cardiac and GI.
09/09/2017

IDMC-11 Session about specific Myotonic Dystrophy features : CNS, Cardiac and GI.

Dr. Artero talking about recent discoveries on Myotonic Dystrophy's disease mechanism during IDMC-11.
08/09/2017

Dr. Artero talking about recent discoveries on Myotonic Dystrophy's disease mechanism during IDMC-11.

Live from IDMC-11 (International Myotonic Dystrophy Consortium Meeting) Day 1
07/09/2017

Live from IDMC-11
(International Myotonic Dystrophy Consortium Meeting) Day 1

Attending the IDMC 11 next September, see you in San Francisco!!!
20/07/2017

Attending the IDMC 11 next September, see you in San Francisco!!!

Because of those promising results it was decided to keep researching and, at the beginning of 2015, one of our projects...
14/06/2017

Because of those promising results it was decided to keep researching and, at the beginning of 2015, one of our projects with the acronym Myo-DM1 got the approval for a competitive program, PID of CDTI. This project’s title is “Development of food supplements to improve the quality of life of patients suffering from Myotonic Distrophy type 1 (DM1)” and has a duration of approximately 2 years (2015-2017).

To give continuity to these results, InKemia IUCT Group has agreed to license the obtained discoveries in this project to its spin-off Myogem Health Company S.L. so we could bring them forward until reaching the people affected of Myotonic Dystrophy.

Dirección

Carrer Álvarez De Castro 63
Mollet Del Vallès
08100

Horario de Apertura

Lunes 09:00 - 18:00
Martes 09:00 - 18:00
Miércoles 09:00 - 18:00
Jueves 09:00 - 18:00
Viernes 09:00 - 18:00

Teléfono

+34 93 579 34 32

Notificaciones

Sé el primero en enterarse y déjanos enviarle un correo electrónico cuando Myogem Health Company S.L. publique noticias y promociones. Su dirección de correo electrónico no se utilizará para ningún otro fin, y puede darse de baja en cualquier momento.

Compartir

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram